Dimagi

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Dimagi sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials 2 currently recruiting 2 completed early-phase tilt upper quartile by trial count

Dimagi: 4 sponsored US clinical trials, 2 recruiting.

Dimagi sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Training of Frontline Health Workers, with 1 trials.

Upper-quartile sponsor footprint

Dimagi sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Dimagi pipeline

2 recruiting of 4 indexed (50% open); 2 completed (50%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Training of Frontline Health Workers (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Dimagi: open-pipeline peers nationwide

Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

Dimagi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60%80% Total trials Recruiting share Dimagi4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action Lab1200 Pharma1ST Biotherapeutics3ive Labs7 Hills Pharma
Dimagi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Dimagi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this Dimagi page

4 registered trials is a research-attention snapshot, not an endorsement of Dimagi or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Dimagi pipeline card: 4 registered trials from official public datasets.Report a data error.